Does treatment with imiquimod enhance antitumor immunity induced by therapeutic HPV DNA vaccination?
Thus, our data suggests that the combination of therapeutic HPV DNA vaccination with topical treatment with the TLR7 agonist imiquimod enhances the antitumor immunity induced by DNA vaccination. The current study has significant implications for future clinical translation.
These data suggest that participation in intravenous alcohol self-administration experiments does not increase subsequent real-life drinking of young adults.